187 related articles for article (PubMed ID: 33815275)
1. Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant.
Duarte DB; Ferreira L; Santos AP; Costa C; Lima J; Santos C; Afonso M; Teixeira MR; Carvalho R; Cardoso MH
Front Endocrinol (Lausanne); 2021; 12():609263. PubMed ID: 33815275
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
[TBL] [Abstract][Full Text] [Related]
3. Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Seabrook AJ; Harris JE; Velosa SB; Kim E; McInerney-Leo AM; Dwight T; Hockings JI; Hockings NG; Kirk J; Leo PJ; Love AJ; Luxford C; Marshall M; Mete O; Pennisi DJ; Brown MA; Gill AJ; Hockings GI; Clifton-Bligh RJ; Duncan EL
J Clin Endocrinol Metab; 2021 Mar; 106(4):1163-1182. PubMed ID: 33367756
[TBL] [Abstract][Full Text] [Related]
4. A Novel Phenotype of Germline Pathogenic Variants in
Chang X; Li Z; Ma X; Cui Y; Chen S; Tong A
Front Endocrinol (Lausanne); 2020; 11():558. PubMed ID: 32973681
[No Abstract] [Full Text] [Related]
5. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.
Comino-Méndez I; Gracia-Aznárez FJ; Schiavi F; Landa I; Leandro-García LJ; Letón R; Honrado E; Ramos-Medina R; Caronia D; Pita G; Gómez-Graña A; de Cubas AA; Inglada-Pérez L; Maliszewska A; Taschin E; Bobisse S; Pica G; Loli P; Hernández-Lavado R; Díaz JA; Gómez-Morales M; González-Neira A; Roncador G; Rodríguez-Antona C; Benítez J; Mannelli M; Opocher G; Robledo M; Cascón A
Nat Genet; 2011 Jun; 43(7):663-7. PubMed ID: 21685915
[TBL] [Abstract][Full Text] [Related]
7. Novel hereditary forms of pheochromocytomas and paragangliomas.
Dahia PL
Front Horm Res; 2013; 41():79-91. PubMed ID: 23652672
[TBL] [Abstract][Full Text] [Related]
8. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
9. Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours.
Flynn A; Dwight T; Benn D; Deb S; Colebatch AJ; Fox S; Harris J; Duncan EL; Robinson B; Hogg A; Ellul J; To H; Duong C; Miller JA; Yates C; James P; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Pathol; 2017 Jul; 242(3):273-283. PubMed ID: 28369925
[TBL] [Abstract][Full Text] [Related]
10. Functional and in silico assessment of MAX variants of unknown significance.
Comino-Méndez I; Leandro-García LJ; Montoya G; Inglada-Pérez L; de Cubas AA; Currás-Freixes M; Tysoe C; Izatt L; Letón R; Gómez-Graña Á; Mancikova V; Apellániz-Ruiz M; Mannelli M; Schiavi F; Favier J; Gimenez-Roqueplo AP; Timmers HJ; Roncador G; Garcia JF; Rodríguez-Antona C; Robledo M; Cascón A
J Mol Med (Berl); 2015 Nov; 93(11):1247-55. PubMed ID: 26070438
[TBL] [Abstract][Full Text] [Related]
11. A Novel MAX Gene Mutation Variant in a Patient With Multiple and "Composite" Neuroendocrine-Neuroblastic Tumors.
Pozza C; Sesti F; Di Dato C; Sbardella E; Pofi R; Schiavi F; Bonifacio V; Isidori AM; Faggiano A; Lenzi A; Giannetta E
Front Endocrinol (Lausanne); 2020; 11():234. PubMed ID: 32508744
[No Abstract] [Full Text] [Related]
12. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
13. Familial Acromegaly and Bilateral Asynchronous Pheochromocytomas in a Female Patient With a
Mamedova E; Vasilyev E; Petrov V; Buryakina S; Tiulpakov A; Belaya Z
Front Endocrinol (Lausanne); 2021; 12():683492. PubMed ID: 34135865
[TBL] [Abstract][Full Text] [Related]
14. Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
Korpershoek E; Koffy D; Eussen BH; Oudijk L; Papathomas TG; van Nederveen FH; Belt EJ; Franssen GJ; Restuccia DF; Krol NM; van der Luijt RB; Feelders RA; Oldenburg RA; van Ijcken WF; de Klein A; de Herder WW; de Krijger RR; Dinjens WN
J Clin Endocrinol Metab; 2016 Feb; 101(2):453-60. PubMed ID: 26670126
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
Vermalle M; Tabarin A; Castinetti F
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
[TBL] [Abstract][Full Text] [Related]
17. Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.
Romanet P; Guerin C; Pedini P; Essamet W; Castinetti F; Sebag F; Roche P; Cascon A; Tischler AS; Pacak K; Barlier A; Taïeb D
Endocr Pathol; 2017 Dec; 28(4):302-307. PubMed ID: 27838885
[TBL] [Abstract][Full Text] [Related]
18. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
19. Clinical description & molecular modeling of novel MAX pathogenic variant causing pheochromocytoma in family, supports paternal parent-of-origin effect.
Richter JE; Hines S; Selvam P; Atwal H; Farres H; Caulfield TR; Atwal PS
Cancer Genet; 2021 Apr; 252-253():107-110. PubMed ID: 33493868
[TBL] [Abstract][Full Text] [Related]
20. MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.
Crona J; Maharjan R; Delgado Verdugo A; Stålberg P; Granberg D; Hellman P; Björklund P
Fam Cancer; 2014 Mar; 13(1):121-5. PubMed ID: 23743562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
